We provide you with 20 years of free, institutional-grade data for AKYA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AKYA. Explore the full financial landscape of AKYA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| McKelligon Brian | Sale | -7,500 | $4.48 | $33,566 | 2023-12-20 |
| McKelligon Brian | Derivatives Exercise | 7,500 | 2023-12-20 | ||
| McKelligon Brian | Sale | -7,500 | $4.25 | $31,871 | 2023-12-14 |
| McKelligon Brian | Derivatives Exercise | 7,500 | 2023-12-14 | ||
| Pla Frederic | Grant, award...etc | 30,000 | 2023-11-27 | ||
| Kamocsay Jennifer | Grant, award...etc | 30,000 | 2023-11-27 | ||
| McKelligon Brian | Sale | -7,500 | $4.39 | $32,901 | 2023-11-22 |
| McKelligon Brian | Derivatives Exercise | 7,500 | 2023-11-22 | ||
| Pla Frederic | Open Market Purchase | 20,000 | $4.6 | 2023-09-11 | |
| Mendel Scott | Open Market Purchase | 20,000 | $5 | 2023-06-12 | |
| Raffin Thomas A. | Open Market Purchase | 1,803,373 | $5 | 2023-06-12 | |
| Raffin Thomas A. | Open Market Purchase | 196,627 | $5 | 2023-06-12 | |
| Raffin Thomas A. | Open Market Purchase | 20,000 | $5 | 2023-06-12 | |
| Winkler Matthew | Open Market Purchase | 203,388 | $5 | 2023-06-12 | |
| SHEPLER ROBERT G | Open Market Purchase | 120,000 | $5 | 2023-06-12 | |
| Ek John Frederick | Open Market Purchase | 20,000 | $5 | 2023-06-12 | |
| LAI GOLDMAN MYLA | Open Market Purchase | 20,000 | $5 | 2023-06-12 | |
| McKelligon Brian | Sale | -5,000 | $5.71 | $28,537 | 2023-06-06 |
| McKelligon Brian | Derivatives Exercise | 5,000 | 2023-06-06 | ||
| Nolan Garry Ph.D. | Sale | -100 | $13.25 | $1,325 | 2023-03-27 |
| Pla Frederic | Sale | -1,945 | $7.69 | $14,957 | 2023-03-27 |
| McKelligon Brian | Sale | -7,437 | $7.69 | $57,191 | 2023-03-27 |
| Ramachandran Niro Ph.D | Sale | -1,945 | $7.69 | $14,957 | 2023-03-27 |
| Kamocsay Jennifer | Grant, award...etc | 37,500 | 2023-03-21 | ||
| Ek John Frederick | Grant, award...etc | 160,000 | 2023-03-21 | ||
| McKelligon Brian | Sale | -5,000 | $9.13 | $45,675 | 2023-03-16 |
| McKelligon Brian | Derivatives Exercise | 5,000 | 2023-03-16 | ||
| El-Gabry Ehab | Grant, award...etc | 16,250 | 2023-02-27 | ||
| Ramachandran Niro Ph.D | Grant, award...etc | 22,500 | 2023-02-27 | ||
| McKelligon Brian | Grant, award...etc | 80,000 | 2023-02-27 | ||
| Pla Frederic | Grant, award...etc | 20,000 | 2023-02-27 | ||
| Moy Marilee | Grant, award...etc | 20,000 | 2023-02-27 | ||
| Ramachandran Niro Ph.D | Derivatives Exercise | 34,000 | 2023-02-17 | ||
| DRISCOLL JOSEPH | Derivatives Exercise | 250,000 | 2022-12-27 | ||
| SCHNETTLER THOMAS P | Sale | -71,050 | $13.03 | $925,782 | 2022-12-20 |
| DRISCOLL JOSEPH | Sale | -24,613 | $12.67 | $311,829 | 2022-12-16 |
| DRISCOLL JOSEPH | Derivatives Exercise | 24,613 | 2022-12-16 | ||
| Nolan Garry Ph.D. | Sale | -100 | $13.25 | $1,325 | 2022-12-15 |
| McKelligon Brian | Sale | -5,000 | $12.08 | $60,415 | 2022-12-08 |
| McKelligon Brian | Derivatives Exercise | 5,000 | 2022-12-08 | ||
| Nolan Garry Ph.D. | Sale | -1,100 | $13.25 | $14,575 | 2022-12-06 |
| Nolan Garry Ph.D. | Sale | -5,000 | $13.36 | $66,788 | 2022-12-02 |
| Nolan Garry Ph.D. | Sale | -300 | $13.25 | $3,976 | 2022-11-17 |
| Nolan Garry Ph.D. | Sale | -24,410 | $13.31 | $324,860 | 2022-11-14 |
| Nolan Garry Ph.D. | Sale | -8,305 | $13.26 | $110,084 | 2022-09-16 |
| Nolan Garry Ph.D. | Sale | -23,991 | $13.31 | $319,294 | 2022-09-13 |
| McKelligon Brian | Sale | -5,000 | $12.83 | $64,170 | 2022-09-09 |
| McKelligon Brian | Derivatives Exercise | 5,000 | 2022-09-09 | ||
| McKelligon Brian | Sale | -5,000 | $10.25 | $51,260 | 2022-06-17 |
| McKelligon Brian | Derivatives Exercise | 5,000 | 2022-06-17 | ||
| Ramachandran Niro Ph.D | Derivatives Exercise | 75,107 | 2022-04-14 | ||
| DRISCOLL JOSEPH | Grant, award...etc | 12,500 | 2022-03-25 | ||
| McKelligon Brian | Grant, award...etc | 80,000 | 2022-03-25 | ||
| Ramachandran Niro Ph.D | Grant, award...etc | 22,500 | 2022-03-25 | ||
| Pla Frederic | Grant, award...etc | 22,500 | 2022-03-25 | ||
| Nolan Garry Ph.D. | Sale | -25,000 | $12.67 | $316,763 | 2021-12-13 |
| Ramachandran Niro Ph.D | Open Market Purchase | 25,073 | $12.85 | 2021-11-22 | |
| Mendel Scott | Open Market Purchase | 8,500 | $13.16 | 2021-11-19 | |
| SHEPLER ROBERT G | Open Market Purchase | 35,000 | $12.17 | 2021-11-18 | |
| Nolan Garry Ph.D. | Initial | 2021-04-20 | |||
| Raffin Thomas A. | Initial | 2021-04-20 | |||
| Winkler Matthew | Initial | 2021-04-20 |
The information provided in this report about AKYA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Akoya BioSciences, Inc.(NASDAQ:AKYA) 
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and...
Website: http://www.akoyabio.com
Founded: 2015
Sector: Healthcare
Industry: Medical Instruments & Supplies
Share this website to your friends